Lyka Labs, a company in the Pharmaceuticals industry, reported revenue of ₹44 crore and net profit of ₹1.27 crore for the September 2026 quarter.
Lyka Labs (NSE: LYKALABS-BE) closed at ₹93.41 on 20 Nov 2026. Its market capitalisation is ₹338 crore.
Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.